Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer

por Alshalalfa, Mohammed, Schliekelman, Mark, Shin, Heesun, Erho, Nicholas, Davicioni, Elai
Publicado 2015

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer

por Erho, Nicholas, Buerki, Christine, Triche, Timothy J., Davicioni, Elai, Vergara, Ismael A.
Publicado 2012

Inferring cancer subnetwork markers using density-constrained biclustering

por Dao, Phuong, Colak, Recep, Salari, Raheleh, Moser, Flavia, Davicioni, Elai, Schönhuth, Alexander, Ester, Martin
Publicado 2010

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

por Tsai, Harrison K., Lehrer, Jonathan, Alshalalfa, Mohammed, Erho, Nicholas, Davicioni, Elai, Lotan, Tamara L.
Publicado 2017

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance

por Boufaied, Nadia, Takhar, Mandeep, Nash, Claire, Erho, Nicholas, Bismar, Tarek A, Davicioni, Elai, Thomson, Axel A
Publicado 2019

Prostate Cancer Tumor Volume and Genomic Risk

por Ramaswamy, Ashwin, Proudfoot, James A., Ross, Ashley E., Davicioni, Elai, Schaeffer, Edward M., Hu, Jim C.
Publicado 2023

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer

por Feng, Ye, Ramnarine, Varune Rohan, Bell, Robert, Volik, Stanislav, Davicioni, Elai, Hayes, Vanessa M., Ren, Shancheng, Collins, Colin C.
Publicado 2019

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

por Vergara, Ismael A., Erho, Nicholas, Triche, Timothy J., Ghadessi, Mercedeh, Crisan, Anamaria, Sierocinski, Thomas, Black, Peter C., Buerki, Christine, Davicioni, Elai
Publicado 2012

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group

por Badani, Ketan, Thompson, Darby J. S., Buerki, Christine, Davicioni, Elai, Garrison, Jill, Ghadessi, Mercedeh, Mitra, Anirban P., Wood, Penelope J., Hornberger, John
Publicado 2013

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases

por Ding, Yuan C., Wu, Huiqing, Davicioni, Elai, Karnes, R. Jeffrey, Klein, Eric A., Den, Robert B., Steele, Linda, Neuhausen, Susan L.
Publicado 2021

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery

por Badani, Ketan K, Thompson, Darby J, Brown, Gordon, Holmes, Daniel, Kella, Naveen, Albala, David, Singh, Amar, Buerki, Christine, Davicioni, Elai, Hornberger, John
Publicado 2015

A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer

por Krentel, Friedemann, Singer, Franziska, Rosano-Gonzalez, María Lourdes, Gibb, Ewan A., Liu, Yang, Davicioni, Elai, Keller, Nicola, Stekhoven, Daniel J., Kruithof-de Julio, Marianna, Seiler, Roland
Publicado 2021

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy

por Handke, Analena, Kesch, Claudia, Fendler, Wolfgang Peter, Telli, Tugce, Liu, Yang, Hakansson, Alexander, Davicioni, Elai, Hughes, Jason, Song, Hong, Lueckerath, Katharina, Herrmann, Ken, Hadaschik, Boris, Seifert, Robert
Publicado 2023

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis

por Lee, Hak J, Yousefi, Kasra, Haddad, Zaid, Abdollah, Firas, Lam, Lucia LC, Shin, Heesun, Alshalalfa, Mohammed, Godebu, Elana, Wang, Song, Shabaik, Ahmed, Davicioni, Elai, Kane, Christopher J
Publicado 2016

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer

por Patel, Neal, Hakansson, Alexander, Ohtake, Shinji, Muraki, Peter, Proudfout, James A., Liu, Yang, Webber, Lisa, Ibarra, Arkaitz, Liu, Vinnie Y. T., Davicioni, Elai, Chamie, Karim, Pantuck, Allan, Shuch, Brian
Publicado 2022

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer

por Sjöström, Martin, Chang, S. Laura, Fishbane, Nick, Davicioni, Elai, Zhao, Shuang G., Hartman, Linda, Holmberg, Erik, Feng, Felix Y., Speers, Corey W., Pierce, Lori J., Malmström, Per, Fernö, Mårten, Karlsson, Per
Publicado 2019

Impact of Decipher on use of post‐operative radiotherapy: Individual patient analysis of two prospective registries

por Shahait, Mohammed, Liu, Vinnie Y. T., Vapiwala, Neha, Lal, Priti, Kim, Jessica, Trabulsi, Eduard J., Huang, Huei‐Chung, Davicioni, Elai, Thompson, Darby J. S., Spratt, Daniel, Den, Robert B., Lee, David I.
Publicado 2021

A comparative study of PCS and PAM50 prostate cancer classification schemes

por Yoon, Junhee, Kim, Minhyung, Posadas, Edwin M., Freedland, Stephen J., Liu, Yang, Davicioni, Elai, Den, Robert B., Trock, Bruce J., Karnes, R. Jeffrey, Klein, Eric A., Freeman, Michael R., You, Sungyong
Publicado 2021

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer

por Prensner, John R., Sahu, Anirban, Iyer, Matthew K., Malik, Rohit, Chandler, Benjamin, Asangani, Irfan A., Poliakov, Anton, Vergara, Ismael A., Alshalalfa, Mohammed, Jenkins, Robert B., Davicioni, Elai, Feng, Felix Y., Chinnaiyan, Arul M.
Publicado 2014

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-contr...

por Tosco, Lorenzo, Laenen, Annouschka, Gevaert, Thomas, Salmon, Isabelle, Decaestecker, Christine, Davicioni, Elai, Buerki, Christine, Claessens, Frank, Swinnen, Johan, Goffin, Karolien, Oyen, Raymond, Everaerts, Wouter, Moris, Lisa, De Meerleer, Gert, Haustermans, Karin, Joniau, Steven
Publicado 2018